Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact

被引:0
作者
Sietske A. Smulders
Chad M. Gundy
Arthur van Lingen
Emile F. Comans
Frank W J M Smeenk
Otto S. Hoekstra
机构
[1] Catharina Hospital Eindhoven,Department of Pulmonary Diseases
[2] VU University,Departments of Clinical Epidemiology and Biostatistics
[3] VU University,Nuclear Medicine and PET research, VU University Medical Centre Amsterdam
来源
Molecular Imaging and Biology | 2007年 / 9卷
关键词
FDG-PET scanning; Interobserver variation; Lung cancer; Experience; Mediastinal lymph node metastases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:318 / 322
页数:4
相关论文
共 49 条
[1]  
Smulders SA(2005)Surgical mediastinal staging in daily practice Lung Cancer 47 243-251
[2]  
Smeenk FW(2003)Value of FDG-PET in the management of non-small cell lung cancer Eur J Radiol 45 49-59
[3]  
Janssen-Heijnen ML(2003)Positron emission tomography with 2-[18f]fluoro-2-deoxy-D-glucose: can it be used to accurately stage the mediastinum in non-small cell lung cancer as an alternative to mediastinoscopy? J Thorac Cardiovasc Surg 126 1700-1703
[4]  
Wielders PL(2001)Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA 285 914-924
[5]  
de Munck DR(2004)Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncology Eur J Nucl Med Mol Imaging 31 596-598
[6]  
Postmus PE(2002)Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 1388-1393
[7]  
Stroobants S(2003)Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer Thorax 58 47-51
[8]  
Verschakelen J(2003)The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment Lung Cancer 39 151-157
[9]  
Vansteenkiste J(1997)Regional lymph node classification for lung cancer staging Chest 111 1718-1723
[10]  
Kernstine KH(1997)Radiology’s Achilles’ heel: error and variation in the interpretation of the Rontgen image Br J Radiol 70 1085-1098